iXensor Co., Ltd. (6734.TWO) Global fertility rates are dropping at alarming rates and the ongoing Covid-19 pandemic is making the situation even worse.
TAIPEI, TAIWAN – December 8th, 2020 – iXensor Co., Ltd. (6734.TWO) Global fertility rates are dropping at alarming rates and the ongoing Covid-19 pandemic is making the situation even worse. Estimates for the US alone assume that up to 500’000 babies won’t be born in 2021 because of it. More than a third of women delay or entirely avoid having babies now due to health concerns and economic uncertainty.
Despite the grim economic outlook, there remains a significant number of women who are trying to conceive, but are not able to because of infertility issues. According to the CDC, over 13% of women aged 15-49 in the USA suffer from impaired fertility.
How Eveline.Care can help
iXensor’s newly introduced Eveline.Care service combines Eveline’s Ovulation Predictor Kit (OPK) with a back-end system that enables fertility professionals to seamlessly access their patients’ recorded ovulation test data. This allows doctors to remotely monitor a patient’s fertility condition and provide comprehensive consultation to help women conceive faster from the safety of their homes.
Eveline’s OPK leverages the user’s smartphone front camera to analyze ovulation test strips and then uses the AI-powered Eveline app to accurately predict up to 7 fertile days per cycle. Users are conveniently reminded through personalized notifications when their fertility status reaches its peak, so that they never miss the perfect time to conceive.
“We see tremendous potential in the adoption of telehealth in the women’s health space. It will not only bring a significant increase in convenience for patients but will also enable more effective treatments. ” iXensor CEO, Dr. Carson Chen
How does Eveline.Care work?
Eveline users authorize participating fertility professionals of their choice to access the fertility data they are recording in the Eveline App. Such data includes their luteinizing hormone (LH) levels, basal body temperature readings (BBT), mood, diet and daily symptoms.
The fertility professional can then remotely monitor the tracked data in real-time and provide personalized fertility advice to the patients through telehealth. In-person practice visits can thus be significantly reduced, resulting in time-savings and minimized exposure to potential viral infections like Covid-19.
Eveline.Care also enables fertility consultants to help women suffering from irregular periods and PCOS by facilitating the diagnosis through the precise LH level data that is recorded in the backend. This allows patients to manage their condition better and ultimately improve their chances of conceiving.
Eveline.Care comes at no additional cost for the patient. All that is required is having the Eveline OPK and a participating medical professional. Our service also safeguards the user’s privacy as the data shared with the fertility consultant can be withdrawn by the patient at any time.
LH & BBT pattern data shown in the back-end of Eveline.Care
About iXensor
iXensor, founded in 2012, is the pioneer of mobile health. iXensor turns smartphones into lab-grade mobile medical diagnostics. In 2017, iXensor introduced the PixoTest® Blood Glucose Monitoring System as the world’s first US FDA approved smartphone camera-based blood test. Based on the core PixoTech® platform, iXensor has ventured into both at-home self-testing and professional clinical diagnostics across infectious diseases, women’s health (Eveline), chronic diseases and cardiovascular diseases. Our vision is to make quality healthcare accessible and timely by driving the paradigm shift of point-of-care testing with the highly scalable PixoTech® platform.
Media Contact
Contact Person: Nicola Krapf
Eveline website: www.evelinecare.com
Company website: www.ixensor.com
Email: pr@ixensor.com
Phone: +1 888-673-1085